Write in a clean editor, then format for Stem Cells Translational Medicine in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Stem Cells Translational Medicine is a peer-reviewed journal published by Wiley, covering Mesenchymal stem cell research, Pluripotent Stem Cells Research, Tissue Engineering and Regenerative Medicine.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Stem Cells Translational Medicine 12 (3): 45–58.
Formats any DOI in Stem Cells Translational Medicine style. No sign-up. |
| Publishes research in | Mesenchymal stem cell research Pluripotent Stem Cells Research Tissue Engineering and Regenerative Medicine Biomedical Ethics and Regulation CRISPR and Genetic Engineering |
| ISSN | 2157-6564 |
| Citation impact (2-yr) | 4.66 |
| h-index | 131 |
| i10-index | 1,490 |
| Total citations | 93,967 |
| Article processing charge | $2,688 |
| Open access | Yes |
| Top institutions publishing here | Inserm |
| Journal website | stemcellsjournals.onlinelibrary.wiley.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Mesenchymal stem cells (MSCs) were officially named more than 25 years ago to represent a class of cells from human and mammalian bone marrow and periosteum that could be isolated and expanded in culture while maintaining their in vitro capacity to be induced to form a variety of mesodermal phenotypes and tissues. The in vitro…
Wound healing requires a coordinated interplay among cells, growth factors, and extracellular matrix proteins. Central to this process is the endogenous mesenchymal stem cell (MSC), which coordinates the repair response by recruiting other host cells and secreting growth factors and matrix proteins. MSCs are self-renewing multipotent stem cells that can differentiate into various lineages of…
UNLABELLED: Although the initial concepts of stem cell therapy aimed at replacing lost tissue, more recent evidence has suggested that stem and progenitor cells alike promote postischemic neurological recovery by secreted factors that restore the injured brain's capacity to reshape. Specifically, extracellular vesicles (EVs) derived from stem cells such as exosomes have recently been suggested…
Mesenchymal stem cells (MSC) hold great potential for regenerative medicine because of their ability for self-renewal and differentiation into tissue-specific cells such as osteoblasts, chondrocytes, and adipocytes. MSCs orchestrate tissue development, maintenance and repair, and are useful for musculoskeletal regenerative therapies to treat age-related orthopedic degenerative diseases and other clinical conditions. Importantly, MSCs produce secretory…
Stem cells obtained from amniotic fluid show high proliferative capacity in culture and multilineage differentiation potential. Because of the lack of significant immunogenicity and the ability of the amniotic fluid-derived stem (AFS) cells to modulate the inflammatory response, we investigated whether they could augment wound healing in a mouse model of skin regeneration. We used…
